trending Market Intelligence /marketintelligence/en/news-insights/trending/SJh5Jej-2CFDTRaEUk4s_A2 content esgSubNav
In This List

Amicus Therapeutics to raise $225M in debt offering

Blog

Insight Weekly: US stock performance; banks' M&A risk; COVID-19 vaccine makers' earnings

Blog

Global M&A By the Numbers: Q3 2021

Blog

Post-webinar Q&A: Global Credit Risk Trends 2021 and Beyond

Blog

University Essentials: From Crisis to Resilience – Navigating Sustainable Recovery


Amicus Therapeutics to raise $225M in debt offering

Amicus Therapeutics Inc. announced a $225 million note offering to refinance a part of its existing debt.

The company plans to issue unsecured convertible notes due 2023 in a private placement with an option to purchase an additional $25 million worth of the debt.

The debt will be priced at a later date.